Increase Revenues and Customer Service Through CRM

CRM on Ulitzer

Subscribe to CRM on Ulitzer: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get CRM on Ulitzer: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


CRM Authors: Brendan Harding, ash, Nadeem ahmed

Related Topics: CRM

News Feed Item

Study and Survey Results, Partnerships, Hotel Openings, and Regulatory Filings - Research Reports on Novartis, WellPoint, Starwood Hotels & Resorts, Omnicom and Ctrip.com

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, September 26, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Novartis AG (NYSE: NVS), WellPoint Inc. (NYSE: WLP), Starwood Hotels & Resorts Worldwide Inc. (NYSE: HOT), Omnicom Group Inc. (NYSE: OMC) and Ctrip.com International Ltd. (NASDAQ: CTRP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6779-100free.

--
Novartis AG Research Reports
On September 19, 2014, Novartis AG (Novartis) reported that according to the data published in The Lancet Oncology, a medical journal, a statistically significant and clinically relevant 4-month improvement was seen in median progression-free survival (PFS) for patients with relapsed or relapsed and refractory multiple myeloma when using the investigational compound LBH589 (panobinostat) in combination with bortezomib and dexamethasone versus placebo plus the same combination. The Company informed that the addition of LBH589 in the Phase III PANORAMA-1 (PANobinostat ORAl in Multiple MyelomA) trial led to clinically meaningful increases in complete and near complete response rates and duration of response across all patient subgroups. Commenting on the results, Alessandro Riva, MD, Global Head, Novartis Oncology Development and Medical Affairs stated, "The PANORAMA-1 results provide strong evidence of the potential impact LBH589 could have for the multiple myeloma community. We are committed to working with regulatory authorities to make this treatment available to patients as soon as possible." The full research reports on Novartis are available to download free of charge at:

http://www.analystsreview.com/Sep-26-2014/NVS/report.pdf

--
WellPoint Inc. Research Reports
On September 22, 2014, WellPoint Inc. (WellPoint) reported the results of its ORC International CARAVAN® Survey that asked Americans what products make their lives easier. The survey results revealed that integrated products and services are highly valued by the consumers. 81% of the consumers stated that it would be extremely helpful to trust the same carrier to provide their dental, vision and health coverage. Survey respondents stated that when it comes to selecting an insurance plan, cost is an extremely important aspect (67%), followed by comprehensiveness of coverage (61%), customer service (60%), and ease of use (58%). Also, 86% respondents expect to save money or receive improved care if the same carrier integrated dental with vision and medical benefits. WellPoint stated that multiline carriers like the Company can provide employers and employees with the exceptional value through simpler processes, vast networks and discounts. Dani Fjelstad, President of WellPoint's Dental business said, "We're meeting the needs of both employer and employee by providing affordable and comprehensive coverage benefits, which helps both save money and time every step of the way." The full research reports on WellPoint are available to download free of charge at:

http://www.analystsreview.com/Sep-26-2014/WLP/report.pdf

--
Starwood Hotels & Resorts Worldwide Inc. Research Reports
On September 18, 2014, Starwood Hotels & Resorts Worldwide Inc. (Starwood Hotels & Resorts) announced that its first Westin hotel in Sarasota, Florida, The Westin Sarasota, will open in the summer of 2016. The new hotel, featuring 255 spacious rooms and spectacular waterfront views, has been developed by Kolter Hospitality LLC. Commenting on the expansion in Florida, Brian Povinelli, Global Brand Leader for Westin & Le Méridien Hotels, stated, "This new Westin hotel will inspire well-being in Sarasota, the cultural center of southwest Florida, within close proximity of the city's best theater, arts and beaches. Here, guests will enjoy all of the Westin brand's signature programs and amenities, designed to send guests home feeling better than when they arrived." The full research reports on Starwood Hotels & Resorts are available to download free of charge at:

http://www.analystsreview.com/Sep-26-2014/HOT/report.pdf

--
Omnicom Group Inc. Research Reports
On September 23, 2014, Omnicom Group Inc. (Omnicom), along with Salesforce.com - a leading Customer Relationship Management (CRM) platform, announced a CRM alliance to create an integrated customer journey platform. The Company stated that this partnership will help its agencies to create highly personalized communications, allowing its clients to create dynamic, end-to-end customer journeys. According to Omnicom, the platform will leverage data from various sources and deliver optimized content to audiences on every channel and every device, and across paid and owned media. The new offering will be managed by Omnicom's data, technology and analytics arm - Annalect. Commenting on the partnership, Jonathan Nelson, CEO, Omnicom Digital, stated, "By bringing together Omnicom with Salesforce, the world's leading CRM, in a way that has never been done before, we will be able to span every consumer-touch point, both online and offline, which is a real first-mover advantage for our clients." The full research reports on Omnicom are available to download free of charge at:

http://www.analystsreview.com/Sep-26-2014/OMC/report.pdf

--
Ctrip.com International Ltd. Research Reports
On September 19, 2014, China-based Ctrip.com International Ltd. (Ctrip.com) filed Form 6-K (Report of Foreign Private Issuer) with US Securities and Exchange Commission (SEC). According to the filing, the Company announced the result of its 2014 annual general meeting held on September 19, 2014. Ctrip.com informed that its shareholders did not vote for the resolutions submitted for approval at this annual meeting and, therefore, the Company's currently effective memorandum and articles of association remain unchanged. The full research reports on Ctrip.com are available to download free of charge at:

http://www.analystsreview.com/Sep-26-2014/CTRP/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.